Distance between valvular leaflet and coronary ostium predicting risk of coronary obstruction during TAVR

Jun-Hyok Oh1, Yuhei Kobayashi2, Guson Kang3

  • 1Department of Cardiology, Medical Research Institute, Pusan National University Hospital, Busan, South Korea.

Insights

A new measurement, Expected Leaflet-to-ostium Distance (ELOD), can help predict coronary artery obstruction after transcatheter aortic valve replacement (TAVR). An ELOD less than 2mm combined with longer leaflet length indicates a higher risk.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Transcatheter aortic valve replacement (TAVR) is a common procedure for aortic stenosis.
  • Coronary artery obstruction is a rare but serious complication following TAVR.
  • Predicting and preventing this complication is crucial for patient safety.

Purpose of the Study:

  • To evaluate the predictive value of the distance between the aortic valve and coronary ostia for coronary artery obstruction post-TAVR.
  • To introduce and validate a novel metric, Expected Leaflet-to-ostium Distance (ELOD), for risk assessment.

Main Methods:

  • Retrospective analysis of pre-TAVR computed tomography (CT) scans from 177 patients.
  • Calculation of ELOD by subtracting leaflet thickness and specific distances from CT measurements.
  • Comparison of variables between patients with and without coronary obstruction, using logistic regression analysis.

Main Results:

  • Analysis included 177 patients and 353 coronary arteries.
  • No significant differences in mean annulus or sinus of Valsalva diameters between groups.
  • Three cases of coronary obstruction were identified. ELOD ≤ 2 mm combined with longer leaflet length was associated with obstruction (log OR = 6.180, p < 0.001).

Conclusions:

  • A combination of ELOD < 2 mm and leaflet length exceeding mid-ostial height may indicate an increased risk of coronary obstruction during TAVR.
  • This finding could aid in pre-procedural risk stratification and planning for TAVR.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
60
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
43
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
64
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
75
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
67
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40